Insider filing · OCUL
Namrata Saroj
Chief Business Officer
profile →
Ocular Therapeutix, Inc.
OCUL · Healthcare · 17 filings in 24 months
ticker →
Namrata Saroj sold $278K of Ocular Therapeutix (OCUL)
Executed Nov 5 2025, disclosed Nov 7 2025, 2 days later.
Value, as filed
$278K
25,865 sh × $10.74
Executed
Nov 5 2025
the trade date, as filed
Disclosed
Nov 7 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
NSNamrata Saroj (Chief Business Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Ocular Therapeutix, Inc. (OCUL). The largest single filing was $278K of OCUL (25,865 sh × $10.74, as filed), executed Nov 5 2025.
The name
OCULHealthcare · Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases a…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→